These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14583079)

  • 1. "Cancer in the family" and genetic testing: implications for life insurance.
    Lynch EL; Doherty RJ; Gaff CL; Macrae FA; Lindeman GJ
    Med J Aust; 2003 Nov; 179(9):480-3. PubMed ID: 14583079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic discrimination: perspectives of consumers.
    Lapham EV; Kozma C; Weiss JO
    Science; 1996 Oct; 274(5287):621-4. PubMed ID: 8849455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing for breast and ovarian cancer: implications for life insurance.
    Lemaire J; Subramanian K; Asch DA
    LDI Issue Brief; 2000 Mar; 5(6):1-4. PubMed ID: 12523344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe.
    Morrison PJ; Steel CM; Vasen HF; Eccles D; Evans DG; Møller P; Hodgson S; Stoppa-Lyonnet D; Chang-Claude J; Caligo M; Olah E; Haites NE; Nevin NC
    Dis Markers; 1999 Oct; 15(1-3):159-65. PubMed ID: 10595272
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigating genetic discrimination in the Australian life insurance sector: the use of genetic test results in underwriting, 1999-2003.
    Otlowski M; Barlow-Stewart K; Taylor S; Stranger M; Treloar S
    J Law Med; 2007 Feb; 14(3):367-96. PubMed ID: 17355100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and benefits of diagnosing familial breast cancer.
    Heimdal K; Maehle L; Møller P
    Dis Markers; 1999 Oct; 15(1-3):167-73. PubMed ID: 10595273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of consumers' experiences and perceptions of genetic discrimination and its impact on utilization of genetic testing.
    Barlow-Stewart K; Taylor SD; Treloar SA; Stranger M; Otlowski M
    Genet Med; 2009 Mar; 11(3):193-201. PubMed ID: 19287242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination.
    Armstrong K; Weber B; FitzGerald G; Hershey JC; Pauly MV; Lemaire J; Subramanian K; Asch DA
    Am J Med Genet A; 2003 Jul; 120A(3):359-64. PubMed ID: 12838555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. British life insurers demand genetic-test results.
    Rogers A; Ramsay S
    Lancet; 1997 Feb; 349(9051):550. PubMed ID: 11654594
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic testing and insurance in Australia.
    Otlowski M; Barlow-Stewart K; Lacaze P; Tiller J
    Aust J Gen Pract; 2019 Mar; 48(3):96-99. PubMed ID: 31256467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding prohibitions against genetic discrimination in insurance.
    Abraham KS
    Jurimetrics; 1999; 40():123-8. PubMed ID: 15744896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insurance underwriting in the genetic era.
    Pokorski RJ
    Cancer; 1997 Aug; 80(3 Suppl):587-99. PubMed ID: 11660561
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic discrimination: meeting the challenges of an emerging issue.
    Otlowski M
    Univ N S W Law J; 2003; 26(3):764-9. PubMed ID: 16617530
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of genetic testing: discrimination in life insurance and future directions.
    Mould A
    J Law Med; 2003 May; 10(4):470-87. PubMed ID: 12852320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of the physician in genetic counselling and testing for heritable breast, ovarian and colon cancer.
    Taylor KM; Kelner MJ
    CMAJ; 1996 Apr; 154(8):1155-8. PubMed ID: 8612250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic discrimination, insurability and legislation: a closing of the legal loopholes.
    Bornstein RA
    J Law Policy; 1996; 4(2):551-610. PubMed ID: 11660776
    [No Abstract]   [Full Text] [Related]  

  • 18. Human Genetics Society of Australasia Position Statement: Genetic Testing and Personal Insurance Products in Australia.
    Newson AJ; Ayres S; Boyle J; Gabbett MT; Nisselle A
    Twin Res Hum Genet; 2018 Dec; 21(6):533-537. PubMed ID: 30458892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing in insurance underwriting: a blessing or a curse? An examination of the tension between economics and equity in using genetic testing in risk classification.
    Anderson MC
    Creighton Law Rev; 1992 Jun; 25(4):1499-535. PubMed ID: 11654461
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetics and Insurance in Australia: Concerns around a Self-Regulated Industry.
    Newson AJ; Tiller J; Keogh LA; Otlowski M; Lacaze P
    Public Health Genomics; 2017; 20(4):247-256. PubMed ID: 29069661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.